Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

INTRODUCTION: Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1–42 (Aβ1–42) in particular with the potential to influence diagnosis. We aimed to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Paterson, Ross W., Toombs, Jamie, Chapman, Miles D., Nicholas, Jennifer M., Heslegrave, Amanda J., Slattery, Catherine F., Foulkes, Alexander J.M., Clark, Camilla N., Lane, Christopher A.S., Weston, Philip S.J., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
CSF Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877931/
https://ncbi.nlm.nih.gov/pubmed/27239518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars